Andrew Adams
Showing 1–3 of 3 transcripts.
Inside Oak HC/FT's $1M to $100M Check Strategy
Annie Lamont, Andrew Adams, Todd Park, Brad Smith, Dave Clark, Molly O'Shea
Annie Lamont, Managing Partner of Oak HCFT, leverages her firm's expanded focus on healthcare and FinTech to deploy horizontal AI platforms while navigating a national security landscape where China has captured half of global non-R&D pharmaceutical spending. Lamont highlights seminal breakthroughs in the industry, including a portfolio company that achieved 100x productivity in antibody design and the rapid scaling of Devoted Health through a technology-driven Medicare Advantage model. With a barbell investment strategy prioritizing top-tier entrepreneurs, the firm is allocating substantial capital to augment clinical workflows and simulate economic agents to address rising administrative costs and rural healthcare disparities.
- a16z7 min
Why America Has A Mental Health Crisis
Amidst severe financial instability in healthcare where half of invoiced dollars remain uncollected, founders Andrew Adams and colleagues at Headway are deploying fintech solutions to bridge the operational gap for solo mental health providers. By repositioning therapists as a unified provider group for payers while offering immediate payment interfaces, the company aims to allow clinicians to accept insurance without traditional administrative burdens. This strategy seeks to normalize mental health access across U.S. insurance cards, transforming a system defined by opacity and 30x price variations into one where therapy is treated equivalently to standard medical facility visits.
- a16z39 min
Two-Sided Networks in Healthcare - a Founder's Playbook
Vineeta Agarwala, Jay Rughani, Vinita, Arif Nthu, Andrew Adams, Iman Abouzeid, Thomas Closel, Doug Hirsch
This event explores the architecture of two-sided healthcare networks that connect the "five P's" of the industry to bridge fragmented data silos and create self-reinforcing value loops. Founders and investors detail specific go-to-market strategies, such as prioritizing demand or supply first, while emphasizing the critical need for early trust-building and the rejection of vanity metrics in favor of qualitative product validation. The discussion further outlines frameworks for scaling to a second side, maintaining network neutrality to prevent disintermediation, and evaluating defensibility against direct transactions as healthcare data infrastructure expands.